ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension

Cardiovascular Research

Volumn 92, Issue 3, 2011, Pages 401-408

  Sriramula, Srinivas ^a   Cardinale, Jeffrey P ^a   Lazartigues, Eric ^b   Francis, Joseph ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACE2; Angiotensin II; Cytokines; Hypertension; Paraventricular nucleus

Indexed keywords

ADENOVIRUS ENCODING HUMAN ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TELEMETRY;

ADENOVIRIDAE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICROINJECTIONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, G-PROTEIN-COUPLED; RENIN-ANGIOTENSIN SYSTEM; TELEMETRY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81055133082     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr242     Document Type: Article

References (40)

1. Brunner HR. Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. Am J Cardiol 2001;87:3C-9C. (Pubitemid 32385756)
2. Allen AM, Zhuo J, Mendelsohn FA. Localization and function of angiotensin AT1 receptors. Am J Hypertens 2000;13:31S-38S. (Pubitemid 30103853)
3. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 2003;144:2179-2183. (Pubitemid 36629863)
4. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006;86:747-803. (Pubitemid 44033382)
5. Davisson RL. Physiological genomic analysis of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2003;285:R498-R511. (Pubitemid 37040553)
6. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: implications for long term control of autonomic output. Clin Exp Pharmacol Physiol 1997;24:96-101. (Pubitemid 27101497)
7. Davern PJ, Head GA. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 2007;49: 1170-1177. (Pubitemid 351664323)
8. McKinley MJ, Allen AM, Burns P, Colvill LM, Oldfield BJ. Interaction of circulating hormones with the brain: the roles of the subfornical organ and the organum vasculosum of the lamina terminalis. Clin Exp Pharmacol Physiol Suppl 1998;25:S61-S67. (Pubitemid 28498851)
9. Swanson LW, Sawchenko PE. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 1983;6:269-324. (Pubitemid 13101466)
10. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994;74:323-364. (Pubitemid 24127645)
11. Tribollet E, Dreifuss JJ. Localization of neurones projecting to the hypothalamic paraventricular nucleus area of the rat: a horseradish peroxidase study. Neuroscience 1981; 6:1315-1328. (Pubitemid 11074861)
12. Bains JS, Potyok A, Ferguson AV. Angiotensin II actions in paraventricular nucleus: functional evidence for neurotransmitter role in efferents originating in subfornical organ. Brain Res 1992;599:223-229. (Pubitemid 23030218)
13. Allen AM. Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone. Hypertension 2002;39:275-280. (Pubitemid 34165228)
14. Ito S, Hiratsuka M, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF. Ventrolateral medulla AT1 receptors support arterial pressure in Dahl salt-sensitive rats. Hypertension 2003;41:744-750. (Pubitemid 36314585)
15. Nakata T, Takeda K, Itho H, Hirata M, Kawasaki S, Hayashi J et al. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats. Am J Hypertens 1989;2:625-630. (Pubitemid 19202867)
16. Kannan H, Hayashida Y, Yamashita H. Increase in sympathetic outflow by paraventricular nucleus stimulation in awake rats. Am J Physiol 1989;256:R1325-R1330.
17. Tagawa T, Dampney RA. AT(1) receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus. Hypertension 1999;34: 1301-1307. (Pubitemid 30002398)
18. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001;38:399-403. (Pubitemid 34225673)
19. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008;51:1345-1351. (Pubitemid 351555948)
20. Lu Y, Chen J, Yin X, Zhao H. Angiotensin II receptor 1 involved in the central pressor response induced by interleukin-1 beta in the paraventricular nucleus. Neurol Res 2009;31:420-424.
21. Sun C, Li H, Leng L, Raizada MK, Bucala R, Sumners C. Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity. J Neurosci 2004;24:9944-9952. (Pubitemid 39463575)
22. Kang YM, Ma Y, Zheng JP, Elks C, Sriramula S, Yang ZM et al. Brain nuclear factorkappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc Res 2009;82:503-512.
23. Xu P, Sriramula S, Lazartigues E. ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am J Physiol Reg, Integr Compar Physiol 2011;300:R804-R817.
24. Ferrario CM. Angiotensin-(1-7) and antihypertensive mechanisms. J Nephrol 1998;11: 278-283. (Pubitemid 29071216)
25. Huentelman MJ, Grobe JL, Vazquez J, Stewart JM, Mecca AP, Katovich MJ et al. Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp Physiol 2005;90:783-790. (Pubitemid 41406067)
26. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002;417:822-828. (Pubitemid 34670323)
27. Diez-Freire C, Vazquez J, Correa de Adjounian MF, Ferrari MF, Yuan L, Silver X et al. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol Genomics 2006;27:12-19. (Pubitemid 44511821)
28. Yamazato M, Yamazato Y, Sun C, Diez-Freire C, Raizada MK. Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes longterm decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 2007;49:926-931. (Pubitemid 351664196)
29. Feng Y, Yue X, Xia H, Bindom SM, Hickman PJ, Filipeanu CM et al. Angiotensinconverting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation. Circ Res 2008;102:729-736. (Pubitemid 351457863)
30. Huentelman MJ, Zubcevic J, Katovich MJ, Raizada MK. Cloning and characterization of a secreted form of angiotensin-converting enzyme 2. Regul Pept 2004;122:61-67. (Pubitemid 39233638)
31. Xia H, Feng Y, Obr TD, Hickman PJ, Lazartigues E. Angiotensin II type 1 receptormediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. Hypertension 2009;53:210-216.
32. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RA et al. Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ Res 2010;106:373-382.
33. Xia H, Lazartigues E. Angiotensin-converting enzyme 2 in the brain: properties and future directions. J Neurochem 2008;107:1482-1494.
34. Lovren F, Pan Y, Quan A, Teoh H, Wang G, Shukla PC et al. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol Heart Circ Physiol 2008;295:H1377-H1384.
35. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C et al. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 2010;107:263-270.
36. Sinnayah P, Lindley TE, Staber PD, Cassell MD, Davidson BL, Davisson RL. Selective gene transfer to key cardiovascular regions of the brain: comparison of two viral vector systems. Hypertension 2002;39:603-608. (Pubitemid 34165191)
37. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003;139:191-202. (Pubitemid 36760351)
38. Koka V, Huang XR, Chung AC, Wang W, Truong LD, Lan HY. Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. Am J Pathol 2008;172:1174-1183. (Pubitemid 351671532)
39. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 2006;47:515-521. (Pubitemid 43843868)
40. Widdop RE, Matrougui K, Levy BI, Henrion D. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension 2002;40:516-520.